The examination says that the diagnosis of prostate cancer is not a death sentence

Prostate cancer statistics may look terrifying: 34,250 deaths in the US in 2024. 1.4 million new cases around the world in 2022.

Dr. Bruce Montgomery, an oncologist of the University of Warsaw, hopes that patients will not see these numbers and simply reject their hands in fear or resignation.

“Diagnosing prostate cancer is not death,” said Montgomery, an elderly author of literature and a test review that appeared in Jama. Montgomery is the clinical director of the genitourinary oncology at the Fred Hutch Cancer Center and the University of Washington Medical Center as well as a professor of medicine and urology at the University of Warsaw School of Medicine.

It encourages patients to ask detailed questions about this cancer. Montgomery also encourages its doctors to cause the issue of prostate cancer screening in their patients.

Knowing whether there is prostate cancer and how risky it can be. Not every cancer must be treated. Sometimes you can simply watch and use active supervision. “

Dr. Bruce Montgomery, Medicine Oncologist of the University of Warsaw

Study 2024 co -author through the UW Medicine Urologist, Dr. Daniel Lin, showed that active supervision can be extremely safe: 0.1% of men who decided to supervise, died of prostate cancer after 10 years.

“We must realize that prostate cancer is not one disease,” said Montgomery. “As a supplier, you need to personalize your approach to the patient you see and to the disease they are personally dealing with.”

For example, if a 50-year-old man develops prostate cancer, which is only in prostate, he may require more aggressive means. However, if a disease that can be slow, develops in an 80-year-old patient, the discussion may be completely different.

“I saw men in the 1980s, developing prostate cancer and did not decide to therapy,” he said. “They know that treatment, such as radiation, can make them feel terrible … so they just say” no “.

He noticed that, like their doctor, you must respect it.

“But if you are 50 and you are 25 to 30 years old, in which prostate cancer can become a bigger problem, even with flaws, most patients should get therapy,” he said.

In the case of more advanced prostate cancer, the number of effective treatment methods developed has increased significantly, as did the survival of men from which prostate cancer spread to other parts of their body.

“Prostate metastatic cancer requires therapy and research over the past 10 to 20 years, has improved and still improves survival,” he said. “Knowing who needs treatment, which to use and when it is both art and science.”

The article included facts that men and their doctors should know, including:

• Every year, about 1.5 million new cases of prostate cancer are diagnosed around the world. About 75% of cases are first detected when the cancer is still located in the prostate. This early detection was associated with a five -year survival rate of almost 100%.
• The proceedings include active supervision, surgical removal of prostatectomy or radiation therapy, depending on the risk of progression.
• About 10% of cases are diagnosed after the spread of cancer. This stage of prostate cancer has a five -year survival rate of 37%.
• The most common prostate cancer is adenoma, a kind that begins in the glandular cells, and the median age in the diagnosis is 67 years.
• Over 50% of the risk of prostate cancer can be attributed to genetic and older factors.

Prostate cancer drew attention in public, both in the country and abroad last year, when the famous local travel writer, Rick Steves, announced that he had developed prostate cancer. Last month he announced his X account, earlier Twitter, that after radiation and surgery at the UW Medicine and Fred Hutch was cancer -free.